Cardio-renal syndromes: A systematic approach for consensus definition and classification

Heart Failure Reviews

Volumn 17, Issue 2, 2012, Pages 151-160

  Ronco, Claudio ^a   Ronco, Federico ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b OSPEDALE DELL'ANGELO   (Italy)

Author keywords

Acute heart failure; Acute kidney injury; Cardio renal syndromea; Chronic heart failure; Chronic kidney disease

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIURETIC AGENT; ERYTHROPOIETIN; FUROSEMIDE; HYPERTENSIVE AGENT; INOTROPIC AGENT; SOTALOL; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; ARTICLE; CARDIORENAL SYNDROME; CARDIORENAL SYNDROME TYPE I; CARDIORENAL SYNDROME TYPE II; CARDIORENAL SYNDROME TYPE III; CARDIORENAL SYNDROME TYPE IV; CARDIORENAL SYNDROME TYPE V; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; CONSENSUS DEVELOPMENT; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EXCRETION; EDEMA; FLUID RESUSCITATION; HEART FAILURE; HEART INJURY; HUMAN; HYPOVOLEMIA; KIDNEY DYSFUNCTION; KIDNEY INJURY; PATHOGENESIS; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE; ULTRAFILTRATION;

EID: 84862579397     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-010-9224-0     Document Type: Article

References (65)

1. Dar O, Cowie MR (2008) Acute heart failure in the intensive care unit: epidemiology. Crit Care Med 36(1 Suppl):S3-S8
2. Schrier RW (2007) Cardiorenal versus reno-cardiac syndrome: is there a difference? Nat Clin Pract Nephrol 3:637
3. Ronco C (2008) Cardiorenal and reno-cardiac syndromes: clinical disorders in search of a systematic definition. Int J Artif Organs 31:1-2
4. Liang KV, Williams AW, Greene EL, Redfield MM (2008) Acute decompensated heart failure and the cardio-renal syndrome. Crit Care Med 36(Suppl 1):S75-S88
5. Ronco C, House AA, Haapio M (2008) Cardio-renal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 34(5):957-962 Epub 2008 Feb 5
6. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52(19):1527-1539
7. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P (2010) For the acute dialysis quality initiative (ADQI) consensus group (2009). Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 31:703-711
8. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardio-renal syndrome: Guyton revisited. Eur Heart J 26:11-17
9. Kelly KJ (2006) Acute renal failure: much more than a kidney disease. Semin Nephrol 26:105-113
10. Berl T, Henrich W (2006) Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1:8-18
11. Kramer BK, Schweds F, Riegger GA (1999) Diuretic treatment and diuretic resistance in heart failure. Am J Med 106:90-96
12. Mebazaa A, Gheorghiade M, Pina IL (2008) Practical recommendations for pre hospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 36(Suppl 1):S129-S139
13. Haldeman GA (1999) Hospitalization of patients with heart failure: National hospital discharge survey, 1985-1995. Am Heart J 137:352-360
14. Adams KF, Fonarow GC, Emerman CL (2005) Characteristics and outcome of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute decompensated heart failure national registry (ADHERE). Am Heart J 149: 209-216
15. Fonarow GC, Gattis Stough W, Abraham WT et al (2007) Characteristics, treatments and outcomes of patients with preserved systolic function hospitalized for heart failure. J Am Coll Cardiol 50:768-777
16. Jose P, Skali H, Anavekar N et al (2006) Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 17:2886-2891
17. Goldberg A, Hammerman H, Petcherski S et al (2005) In-hospital and one year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 150:330-337
18. Tokuyama H, Kelly DJ, Zhang Y et al (2007) Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia. Nephron Physiol 106:p54-p62
19. Ellison DH (1999) Diuretic resistance: physiology and therapeutics. Semin Nephrol 19:581-597
20. Almeshari K, Ahlstrom NG, Capraro FE et al (1993) A volume independent component to post diuretic sodium retention in humans. J Am Soc Nephrol 102:450-458
21. Howard PA, Dunn MI (2001) Aggressive diuresis for severe heart failure in the elderly. Chest 119:610-807
22. Ronco C, Costanzo MR, Bellomo R, Maisel AS (2010) Diagnosis and management of fluid overload in heart failure and cardiorenal syndromes. Contr to Nephrol 164, Karger Basel
23. Mayer J, Boldt J, Wolf MW, Lang J, Sutton S (2008) Cardiac output derived from arterial pressure waveform analysis in patients undergoing cardiac surgery. Validity of a second generation device. Anesth Analg 106:867-872
24. Wan L, Naka T, Uchino S, Bellomo R (2005) A pilot study of pulse contour cardiac output monitoring in patients with septic shock. Crit Care Resusc 7:165-169
25. Nguyen BH, Losey T, Rasmussen BA et al (2006) Interrater reliability of cardiac output measurements by transcutaneous Doppler ultrasound: implications for non-invasive hemodynamic monitoring in the ED. Am J Emerg Med 24:828-835
26. Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49:675-683
27. Verma A, Solomon SD (2007) Optimizing care of heart failure after acute myocardial infarction with an aldosterone receptor antagonist. Curr Heart Fail Rep 4:183-189
28. Chen ZM, Pan HC, Chen YP et al (2005) Early intravenous then oral metoprolol in 45, 852 patients with acute myocardial infarction: a randomized placebo-controlled trial. Lancet 366:1622-1632
29. Yorgun H, Deniz A, Aytemir K (2008) Cardiogenic shock secondary to combination of diltiazem and sotalol. Intern Med J 38:221-222
30. Tessone A, Gottlieb S, Barbash IM et al (2007) Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency. Cardiology 108:193-199
31. McCullough PA (2003) Beyond serum creatinine: defining the patient with renal insufficiency and why? Rev Cardiovasc Med 4(Suppl 1):S2-S6
32. Damman K, Navis G, Voors AA et al (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 28:285-287
33. Hillege HL, Nitsch D, Pfeffer MA et al (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671-678
34. Bhatia RS, Tu JV, Lee DS et al (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260-269
35. Jie KE, Verhaar MC, Cramer MJ et al (2006) Erythropoietin and the cardio-renal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol 291:F392-F444
36. Palazzuoli A, Silverberg DS, Iovine F et al (2007) Effects of betaerythropoietin treatment of left ventricular remodelling, systolic function, and B-type natriuretic peptide levels in patients with the cardio-renal anemia syndrome. Am Heart J 154:e9-e15
37. Butler J, Forman DE, Abraham WT et al (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147: 331-339
38. McCullough PA (2002) Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med 3:71-76
39. Wright RS, Reeder GS, Herzog CA et al (2002) Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137:563-570
40. Beattie JN, Soman SS, Sandberg KR et al (2001) Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37:1191-1200
41. Gibson CM, Pinto DS, Murphy SA et al (2003) Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 42:1535-1543
42. Berger AK, Duval S, Krumholz HM (2003) Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 42:201-208
43. French WJ, Wright RS (2003) Renal insufficiency and worsened prognosis with STEMI: a call for action. J Am Coll Cardiol 42:1544-1546
44. Levin A, Foley RN (2000) Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 36(Suppl 3):S24-S30
45. Keltai M, Tonelli M, Mann JF et al (2007) Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Eur J Cardiovasc Pre Rehab 14:312-318
46. Ruggenenti P, Perna A, Remuzzi G (2001) ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril efficacy in nephropathy. J Am Soc Nephrol 12:2832-2837
47. Fung JW, Szeto CC, Cahn JY et al (2007) Prognostic value of renal function in patients with cardiac resynchronization therapy. In J Cardiol 122:10-16
48. Gheorghiade M, Niazi I, Ouyang J et al (2003) Vasopressin-V-2 receptor blockade with tolvaptan in patients with chronic heart failure: results of a double-blind randomized trial. Circulation 107:2690-2696
49. Konstan MA, Gheorghiade M, Burnett JC Jr et al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297:1319-1331
50. Uchino S, Bellomo R, Goldsmith D, Bates S (2006) An assessment of the RIFLE criteria for ARF in hospitalized patients. Crit Care Med 34:1913-1917
51. Bagshaw SM, George C, Dinu I, Bellomo R (2007) A multicenter evaluation of the RIFLE criteria of early acute kidney injury in critically ill patients. Nephrol Dial Transplant 23(4):1203-1210 Oct 25 [E-pub]
52. Blake P, Hasegawa Y, Khosla MC et al (1996) Isolation of myocardial depressant factor(s) from the ultra filtrate of heart failure patients with acute renal failure. ASAIO J 42:M911-M915
53. Meyer TW, Hostetter TH (2007) Uremia. N Engl J Med 357: 1316-1325
54. Figueras J, Stein L, Diez V et al (1976) Relationship between pulmonary hemodynamics and arterial pH and carbon dioxide tension in critically ill patients. Chest 70:466-472
55. Brady JP, Hasbargen JA (2000) A review of the effects of acidosis on nutrition in dialysis patients. Semin Dial 13:252-255
56. McCullough PA, Sandberg KR (2004) Chronic kidney disease and sudden death: strategies for prevention. Blood Purif 22: 136-142
57. Selby NM, McIntyre CW (2007) The acute cardiac effects of dialysis. Semin Dial 20(3):220-228
58. Ronco C, Bellomo R, Ricci Z (2001) Continuous renal replacement therapy in the critically ill patients. Nephrol Dial Transplant 16(Suppl 5):67-72
59. Sarnak MJ, Levey AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 42:1050-1065
60. Chertow GM, Normand SL, Silva LR, McNeil BJ (2000) Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. Am J Kidney Dis 35:1044-1051
61. Herzog CA (2002) Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome? Nephrol Dial Transplant 17:7-10
62. KDOQI group (2003) Diagnosis and evaluation of patients with chronic kidney disease: recommendations from the National Kidney Foundation. Ann Intern Med 139:I36
63. Johnson DW, Craven AM, Isbel NM (2007) Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodial Int 11:1-14
64. Logar CM, Herzog CA, Beddhu S (2003) Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations. Am J Med Sci 325: 214-227
65. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA (2003) Chronic kidney disease and cardiovascular disease in the medicare population. Kidney Int 87(Suppl 4):S24-S31